<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype by cytogenetic analysis (CA) corresponds to a low cytogenetic risk for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) evolution, a subset of patients however develops <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the use of interphase fluorescence in situ hybridisation (I-FISH) in 31 patients with evolution from primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and a <z:mpath ids='MPATH_458'>normal</z:mpath> CA at <z:hpo ids='HP_0000001'>all</z:hpo> stages of disease </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0004026'>Monosomy</z:mp> 7 was found in 4/31 cases, one patient had a terminal deletion 5q, each after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> evolution </plain></SENT>
<SENT sid="3" pm="."><plain>The low frequency and unclear prognostic value of I-FISH anomalies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> suggests that these alterations play a minor role for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> evolution </plain></SENT>
</text></document>